Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Intellia Therapeutics, Inc. | StockGist | StockGist

Companies
NTLA
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings NTLASCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Intellia Therapeutics, Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001652130

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Intellia Therapeutics, Inc.

Person Type

HC

CUSIP: 45826J105

Amendment History

8 filings

SCHEDULE 13G
Original
Viewing
Feb 9, 20260000093751-26-000056
SCHEDULE 13G/A
Amendment 1
Jan 8, 20250000932471-25-000028
SCHEDULE 13G/A
Amendment 2
Apr 17, 20250001576419-25-000614
SCHEDULE 13G/A
Amendment 3
Nov 4, 20250001104659-25-106358
SCHEDULE 13G/A
Amendment 4
Jan 30, 20260000102909-26-000156
SCHEDULE 13G/A
Amendment 5
Feb 3, 20260001104659-26-009584
SCHEDULE 13G/A
Amendment 6
Feb 11, 20260001999371-26-003032
SCHEDULE 13G/A
Amendment 7
Latest
Feb 12, 20260000886982-26-000085

Recent Filings

Intellia Therapeutics, Inc.1 months ago

Intellia Therapeutics, Inc.1 months ago

Intellia Therapeutics, Inc.1 months ago

Intellia Therapeutics, Inc.1 months ago

Intellia Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice